TNF - tumor necrosis factor Gene
Also Known as TNFA; TNLG1F
Species: Felis catus
Gene Type: protein coding
Gene ID: 493755
TNF Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001009835.1 | NP_001009835.1 | tumor necrosis factor precursor |
TNF Protein Structure
TNF
TNF: pfam00229 (101 - 232)
- 0
- 100
- 200
- 233 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tumor necrosis factor |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(44)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1272 | Desipramine hydrochloride | Inhibitor | 99.76% | Unkown |
| HY-108910 | Chymotrypsin | Inhibitor | / | Unkown |
| HY-12085 | Apremilast | 99.87% | Yes | |
| HY-A0170 | Trovafloxacin | Inhibitor | 99.43% | Unkown |
| HY-B1077 | Penfluridol | 99.93% | Unkown | |
| HY-103399 | Trovafloxacin mesylate | Inhibitor | 99.76% | Unkown |
| HY-N0281 | Daphnetin | 99.77% | Unkown | |
| HY-B1172 | Lactulose | 99.90% | Yes | |
| HY-B1201 | Tiratricol | Inhibitor | 98.88% | Yes |
| HY-13682 | Mifamurtide | 99.58% | Unkown | |
| HY-B0679 | Lubiprostone | 99.09% | Yes | |
| HY-30235A | Benzydamine hydrochloride | Inhibitor | 99.21% | Unkown |
| HY-B0742 | Hydroxyprogesterone caproate | Ligand | 99.29% | Yes |
| HY-W013150 | Alpidem | Ligand | 99.70% | Unkown |
| HY-B1051 | Flumethasone | 99.84% | Unkown | |
| HY-B0164 | Mizolastine | Antagonist | 99.82% | Unkown |
| HY-B1197 | Amcinonide | 99.11% | Unkown | |
| HY-B0898 | Ceftiofur sodium | Inhibitor | 98.02% | Unkown |
| HY-145583 | Mufemilast | Inhibitor | 99.67% | Unkown |
| HY-B1608 | Chromium chloride | 99.9% | Unkown | |
| HY-100607A | Landiolol hydrochloride | 99.96% | Unkown | |
| HY-N7102 | Ceftiofur | Inhibitor | 99.81% | Unkown |
| HY-12642 | Diethylcarbamazine citrate | Inhibitor | 98.01% | Unkown |
| HY-B0513 | Methylthiouracil | Inhibitor | 98.0% | Unkown |
| HY-B1451A | Imidapril | Inhibitor | 99.0% | Yes |
| HY-12642A | Diethylcarbamazine | Inhibitor | 99.83% | Unkown |
| HY-13682B | Mifamurtide sodium | 99.92% | Unkown | |
| HY-B0446 | Naphazoline hydrochloride | 99.38% | Unkown | |
| HY-111326A | Naphazoline nitrate | 99.12% | Unkown | |
| HY-111326 | Naphazoline | 99.74% | Unkown | |
| HY-B0742R | Hydroxyprogesterone caproate (Standard) | Ligand | 99.21% | Unkown |
| HY-B1451 | Imidapril hydrochloride | Inhibitor | 99.91% | Yes |
| HY-13682C | Mifamurtide TFA | 98.0% | Unkown | |
| HY-B0026 | Ceftiofur hydrochloride | Inhibitor | 98.43% | Unkown |
| HY-133829 | Zofenoprilat | 97.5% | Unkown | |
| HY-109569 | Vitamin K2 | ≥98.0% | Unkown | |
| HY-B1272R | Desipramine hydrochloride (Standard) | 99.03% | Unkown | |
| HY-B1615 | Clenbuterol | Agonist | / | Unkown |
| HY-100607 | Landiolol | / | Unkown | |
| HY-B1272A | Desipramine | / | Unkown | |
| HY-12642AR | Diethylcarbamazine (Standard) | Inhibitor | / | Unkown |
| HY-12642R | Diethylcarbamazine citrate (Standard) | Inhibitor | / | Unkown |
| HY-30235 | Benzydamine | Inhibitor | / | Unkown |
| HY-B0164A | Mizolastine dihydrochloride | Antagonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9908 | Adalimumab | Inhibitor | 99.62% | Unkown |
| HY-P9970 | Infliximab | Inhibitor | 90.30% | Unkown |
| HY-108847 | Etanercept | Inhibitor | 99.20% | Unkown |
| HY-P99111 | Golimumab | 99.81% | Unkown | |
| HY-P99796 | Ozoralizumab | Inhibitor | 99.80% | Unkown |
| HY-P9953 | Certolizumab pegol | Inhibitor | 99.30% | Unkown |
Clinical Phase
Bioactive Molecules
(50)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-Y0344D | Sodium chloride, for cell culture | Activator | 99.9% | Phase 4 |
| HY-N3021 | D-chiro-Inositol | Inhibitor | 98.0% | Phase 4 |
| HY-N7493 | N-acetyldopamine | Inhibitor | 99.36% | Phase 4 |
| HY-Y0344J | Sodium chloride, for molecular biology | 99.97% | Phase 4 | |
| HY-Y0344I | Sodium chloride, meets analytical specification of Ph. Eur. BP USP, ≤0.00002% Al | 99.99% | Phase 4 | |
| HY-N8277 | Kdo2-Lipid A ammonium | 99.00% | Phase 4 | |
| HY-Y0344H | Sodium chloride, United States Pharmacopeia (USP) Reference Standard | / | Phase 4 | |
| HY-114360AS1 | Taurohyodeoxycholic acid-d4 sodium | Inhibitor | / | Phase 4 |
| HY-11109 | Resatorvid | Inhibitor | 99.95% | Phase 3 |
| HY-105028 | Tenidap | 99.93% | Phase 3 | |
| HY-13743 | Roquinimex | Inhibitor | 99.69% | Phase 3 |
| HY-121356 | Carebastine | 99.23% | Phase 3 | |
| HY-148511 | Vidutolimod | 93.85% | Phase 3 | |
| HY-13743R | Roquinimex (Standard) | Inhibitor | / | Phase 3 |
| HY-13740 | Resiquimod | 99.95% | Phase 2 | |
| HY-16591 | Birinapant | 99.70% | Phase 2 | |
| HY-110133 | JTE-607 | Inhibitor | 99.27% | Phase 2 |
| HY-10406 | Talmapimod | 98.68% | Phase 2 | |
| HY-N9965 | 2'-Fucosyllactose | Inhibitor | 99.97% | Phase 2 |
| HY-15509A | Semapimod tetrahydrochloride | Inhibitor | 99.18% | Phase 2 |
| HY-119307 | Apratastat | Inhibitor | 99.28% | Phase 2 |
| HY-108910A | Chymotrypsin (MS grade) | Inhibitor | / | Phase 2 |
| HY-139481 | TL-895 | Inhibitor | 99.86% | Phase 2 |
| HY-105017 | Evodenoson | Agonist | 99.94% | Phase 2 |
| HY-164894 | ABBV-3373 | Inhibitor | 98.78% | Phase 2 |
| HY-18862 | PF-03715455 | Inhibitor | 98.44% | Phase 2 |
| HY-147263 | Dovramilast | Inhibitor | 99.66% | Phase 2 |
| HY-108622 | Mesopram | Inhibitor | 98.80% | Phase 2 |
| HY-164893 | ABBV-154 | Inhibitor | 96.23% | Phase 2 |
| HY-100376 | CPI-1189 | Inhibitor | 99.82% | Phase 2 |
| HY-108047 | MK-0873 | Inhibitor | 95.0% | Phase 2 |
| HY-U00179 | CDC801 | Inhibitor | 98.94% | Phase 2 |
| HY-10406A | Talmapimod hydrochloride | / | Phase 2 | |
| HY-106377 | BIO-11006 | Inhibitor | / | Phase 2 |
| HY-111167 | AN-2898 | Inhibitor | / | Phase 2 |
| HY-114766 | Pumafentrine | Inhibitor | / | Phase 2 |
| HY-119348 | Nitroparacetamol | Inhibitor | / | Phase 2 |
| HY-14869 | Revamilast | Inhibitor | / | Phase 2 |
| HY-13518 | Piceatannol | 98.97% | Phase 1 | |
| HY-10172 | IMD-0354 | Inhibitor | 99.26% | Phase 1 |
| HY-107390 | AX-024 | Inhibitor | 99.73% | Phase 1 |
| HY-160406 | SNX281 | 98.96% | Phase 1 | |
| HY-19717 | DCVC | Inhibitor | 99.78% | Phase 1 |
| HY-107390A | AX-024 hydrochloride | Inhibitor | 99.23% | Phase 1 |
| HY-163102 | IA-14069 | Inhibitor | 99.93% | Phase 1 |
| HY-15507 | VGX-1027 | Inhibitor | 99.67% | Phase 1 |
| HY-114214 | CKD-712 | / | Phase 1 | |
| HY-120434 | AEG40826 | Inhibitor | / | Phase 1 |
| HY-123765 | JTT-553 | Inhibitor | / | Phase 1 |
| HY-N8691 | 2',6'-Dihydroxy-4'-methoxydihydrochalcone | Inhibitor | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(32)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99830 | Conbercept | Inhibitor | 98.42% | Phase 4 |
| HY-P991028 | Surovatamig | Inhibitor | 99.89% | Phase 3 |
| HY-P9983 | Lintuzumab | Inhibitor | 98.09% | Phase 3 |
| HY-P990070 | Zigakibart | Inhibitor | 99.30% | Phase 3 |
| HY-P99252 | Itolizumab | ≥99.0% | Phase 3 | |
| HY-P99499 | Cetrelimab | ≥99.0% | Phase 3 | |
| HY-P99578 | Tanfanercept | Inhibitor | / | Phase 3 |
| HY-P99692 | Lenercept | Inhibitor | / | Phase 3 |
| HY-P99772 | Onfekafusp alfa | / | Phase 3 | |
| HY-P99008 | Atibuclimab | Inhibitor | ≥99.0% | Phase 2 |
| HY-P99670 | Iscalimab | Inhibitor | 99.64% | Phase 2 |
| HY-P991192 | BI-1808 | Inhibitor | 97.75% | Phase 2 |
| HY-P99940 | Remtolumab | Inhibitor | 99.24% | Phase 2 |
| HY-P99393 | Tavolixizumab | Inhibitor | 99.66% | Phase 2 |
| HY-P99178 | CTX-471 | / | Phase 2 | |
| HY-P99704 | Licaminlimab | Inhibitor | 96.10% | Phase 2 |
| HY-P99775 | Placulumab | Inhibitor | 96.84% | Phase 2 |
| HY-P991091 | COVA322 | Inhibitor | / | Phase 2 |
| HY-P991324 | MEDI-7352 | Inhibitor | / | Phase 2 |
| HY-P991408 | DLX-105 | Inhibitor | / | Phase 2 |
| HY-P99543 | Tulinercept | Inhibitor | / | Phase 2 |
| HY-P991610 | S-095029 | Inhibitor | / | Phase 2 |
| HY-P991049 | Atrosimab | Inhibitor | 99% | Phase 1 |
| HY-P99361 | Enavatuzumab | Inhibitor | 98.27% | Phase 1 |
| HY-P99390 | Tepoditamab | Inducer | ≥99% | Phase 1 |
| HY-P991193 | NGM-438 | Activator | 99.74% | Phase 1 |
| HY-P99945 | Revdofilimab | Activator | 99.35% | Phase 1 |
| HY-P99916 | Emirodatamab | Inhibitor | 99.05% | Phase 1 |
| HY-P991364 | Aldastotug | Inhibitor | 99.9% | Phase 1 |
| HY-P3385 | Rilunermin alfa | Inducer | / | Phase 1 |
| HY-P991393 | ASP8374 | / | Phase 1 | |
| HY-P991634 | IBI-325 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(975)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13453 | BAY 11-7082 | 99.98% | Unkown | |
| HY-N0822 | Shikonin | Inhibitor | 99.80% | Unkown |
| HY-15648B | GSK-J4 | 99.45% | Unkown | |
| HY-N0171A | Beta-Sitosterol (purity>98%) | 99.74% | Unkown | |
| HY-P0224 | N-Formyl-Met-Leu-Phe | Inhibitor | 99.90% | Unkown |
| HY-P1860 | TNF-α (31-45), human | 99.99% | Unkown | |
| HY-126360 | Oxazolone | 98.0% | Unkown | |
| HY-103490 | Takinib | 99.48% | Unkown | |
| HY-108473 | CU-CPT 4a | Inhibitor | 99.50% | Unkown |
| HY-110203 | R-7050 | Antagonist | 99.96% | Unkown |
| HY-B1670A | (-)-Isoproterenol hydrochloride | Inhibitor | 99.97% | Unkown |
| HY-160412 | Balinatunfib | Inhibitor | 99.94% | Unkown |
| HY-138682 | STING-IN-2 | Inhibitor | 99.71% | Unkown |
| HY-12326A | c-di-AMP disodium | Agonist | 99.14% | Unkown |
| HY-123942 | Diprovocim | Agonist | 98.82% | Unkown |
| HY-13812 | QNZ | Inhibitor | 99.50% | Unkown |
| HY-16657 | TAPI-1 | 99.36% | Unkown | |
| HY-N0171 | Beta-Sitosterol (purity>80%) | Inducer | ≥98.0% | Unkown |
| HY-163731 | EGR-1-IN-1 | Inhibitor | 99.07% | Unkown |
| HY-122882 | HOIPIN-8 | 98.90% | Unkown | |
| HY-N0637 | Eriodictyol | Inhibitor | 99.55% | Unkown |
| HY-134816 | D-Glucan | 96.0% | Unkown | |
| HY-N0029 | Forsythoside B | 99.90% | Unkown | |
| HY-15648F | GSK-J4 hydrochloride | Inhibitor | 99.01% | Unkown |
| HY-N0194 | Asiatic acid | 99.49% | Unkown | |
| HY-133122 | UCB-9260 | Inhibitor | 99.36% | Unkown |
| HY-111255 | SPD304 | Inhibitor | 99.72% | Unkown |
| HY-100339 | GSK583 | Inhibitor | 99.93% | Unkown |
| HY-N0405 | Orientin | Inhibitor | 99.89% | Unkown |
| HY-N0722 | Neochlorogenic acid | Inhibitor | 99.80% | Unkown |
| HY-N0509 | Astilbin | 99.80% | Unkown | |
| HY-112904 | XRK3F2 | Inhibitor | 99.08% | Unkown |
| HY-100211 | TAPI-2 | Inhibitor | 97.41% | Unkown |
| HY-N0297 | Sinensetin | Inhibitor | 99.62% | Unkown |
| HY-N0472 | Geraniin | Inhibitor | 99.82% | Unkown |
| HY-N6796 | Manumycin A | 99.27% | Unkown | |
| HY-P1924 | IRBP(651-670) human, mouse | Activator | 99.64% | Unkown |
| HY-A0103 | Xanthan gum | / | Unkown | |
| HY-NP004 | Cobra Venom Factor | Activator | 99.07% | Unkown |
| HY-109804 | CORM-401 | Inhibitor | 98.60% | Unkown |
| HY-134471 | TNF-α-IN-2 | Inhibitor | 99.2% | Unkown |
| HY-107427 | PF-3644022 | Inhibitor | 99.91% | Unkown |
| HY-134240 | L-Threonic acid magnesium | ≥99.0% | Unkown | |
| HY-107737 | 1,2-DLPC | Activator | 98.0% | Unkown |
| HY-147141 | HS-276 | Inhibitor | 98.93% | Unkown |
| HY-N0633 | Muscone | Inhibitor | 98.0% | Unkown |
| HY-N0604 | Ginsenoside Rh1 | Inhibitor | 98.72% | Unkown |
| HY-13229 | BOC-D-FMK | Inhibitor | 95.0% | Unkown |
| HY-110353 | CU-T12-9 | Agonist | 99.96% | Unkown |
| HY-114360 | Taurohyodeoxycholic acid | Inhibitor | 99.73% | Unkown |
| HY-N0569 | Madecassic acid | Inhibitor | 99.93% | Unkown |
| HY-N0043 | Ginsenoside Rd | Inhibitor | 99.88% | Unkown |
| HY-19744 | T6167923 | Inhibitor | 99.40% | Unkown |
| HY-N0042 | Ginsenoside Rc | 98.0% | Unkown | |
| HY-P4855 | CRAMP (mouse) | Activator | 98.97% | Unkown |
| HY-128686 | KAG-308 | Agonist | 99.60% | Unkown |
| HY-142618 | TNF-α-IN-6 | Inhibitor | 99.58% | Unkown |
| HY-156454 | UCB-6876 | Inhibitor | 98.49% | Unkown |
| HY-19975 | RN-1734 | Antagonist | 99.75% | Unkown |
| HY-W010201 | Citronellol | 98.40% | Unkown | |
| HY-170621 | STAT1/3-IN-1 | Inhibitor | 99.23% | Unkown |
| HY-N9445 | Lacto-N-neotetraose | 99.92% | Unkown | |
| HY-125527 | Resolvin D1 | 99.60% | Unkown | |
| HY-N2464 | Maltotetraose | Inhibitor | 99.88% | Unkown |
| HY-159520 | Ofirnoflastum | 99.93% | Unkown | |
| HY-N0619 | Mulberroside A | Inhibitor | 99.92% | Unkown |
| HY-150725C | ODN 1585 sodium | Inducer | 93.90% | Unkown |
| HY-155998 | NF-κB-IN-11 | Inhibitor | 98.42% | Unkown |
| HY-N0171R | Beta-Sitosterol (Standard) | Inducer | 98.18% | Unkown |
| HY-125402 | GSK-843 | 99.53% | Unkown | |
| HY-19667A | BMS-561392 formate | 99.13% | Unkown | |
| HY-N6607 | Tryptanthrin | 99.89% | Unkown | |
| HY-B0392 | (S)-(+)-Rolipram | 99.96% | Unkown | |
| HY-108642B | AMG-548 dihydrochloride | Inhibitor | 99.86% | Unkown |
| HY-14622 | Necrostatin 2 | Inhibitor | 99.78% | Unkown |
| HY-103360 | J-113863 | Antagonist | ≥99.0% | Unkown |
| HY-148141 | JPE-1375 | Antagonist | 99.96% | Unkown |
| HY-15511 | Tyrphostin A9 | Inhibitor | 99.91% | Unkown |
| HY-119459 | Fluopyram | 99.76% | Unkown | |
| HY-150725 | ODN 1585 | Inducer | 92.48% | Unkown |
| HY-N0481 | Roburic acid | 99.93% | Unkown | |
| HY-136339 | Cbl-b-IN-1 | Inhibitor | 99.66% | Unkown |
| HY-N0852 | Benzoylpaeoniflorin | 99.35% | Unkown | |
| HY-114360A | Taurohyodeoxycholic acid sodium | Inhibitor | 99.99% | Unkown |
| HY-131249 | MK2-IN-3 | Inhibitor | 99.15% | Unkown |
| HY-N0936 | Coixol | Inhibitor | 98.56% | Unkown |
| HY-N1949 | Homoplantaginin | Inhibitor | 99.70% | Unkown |
| HY-P11072 | IRF5-CPP5 | Inhibitor | 99.23% | Unkown |
| HY-12557 | γ-Glutamylvaline | 99.94% | Unkown | |
| HY-N0041 | Ginsenoside Rb3 | Inhibitor | 99.87% | Unkown |
| HY-N0803 | Myrcene,75% (stabilized with BHT) | Inhibitor | 75.0% | Unkown |
| HY-147045 | UCB-5307 | Inhibitor | 97.09% | Unkown |
| HY-133807 | Benpyrine | Inhibitor | 99.26% | Unkown |
| HY-12700 | RO5256390 | Agonist | 98.75% | Unkown |
| HY-N2392 | Kukoamine A | 99.88% | Unkown | |
| HY-P3023 | Mutanolysin | Inhibitor | / | Unkown |
| HY-W040045 | Callistephin chloride | Inhibitor | 98.31% | Unkown |
| HY-159069 | Zymosan (ZM), 95% | 96.11% | Unkown | |
| HY-110177 | SP-100030 | Inhibitor | 99.57% | Unkown |
| HY-124151 | Adenosine-2'-monophosphate | Activator | 99.91% | Unkown |
| HY-128754 | Monoolein | Inhibitor | 99.91% | Unkown |
| HY-N0316 | Mollugin | 99.79% | Unkown | |
| HY-101849 | Fasentin | 98.0% | Unkown | |
| HY-114869 | DPQ | Inhibitor | 99.68% | Unkown |
| HY-118694 | TAPI-0 | Inhibitor | 97.06% | Unkown |
| HY-N6253 | Pinoresinol | Inducer | 99.48% | Unkown |
| HY-N7637 | Tubuloside B | Inhibitor | 99.95% | Unkown |
| HY-P1832A | PTD-p65-P1 Peptide TFA | 99.92% | Unkown | |
| HY-101448 | TMI-1 | 99.57% | Unkown | |
| HY-N6866 | Gomisin N | 99.94% | Unkown | |
| HY-P4744A | LL-37 amide TFA | Inhibitor | 99.97% | Unkown |
| HY-111255A | SPD304 dihydrochloride | Inhibitor | 99.82% | Unkown |
| HY-120149 | Inotodiol | 98.29% | Unkown | |
| HY-132248 | C5 Lenalidomide | Inhibitor | 99.62% | Unkown |
| HY-N2110 | Phellopterin | 99.94% | Unkown | |
| HY-P4846 | Ac-Pro-Gly-Pro-OH | 99.49% | Unkown | |
| HY-128598 | MD2-TLR4-IN-1 | Inhibitor | 98.16% | Unkown |
| HY-N0626 | Sorbic acid | Inhibitor | 99.98% | Unkown |
| HY-W099602 | Dodecane | Activator | 99.92% | Unkown |
| HY-100735 | C 87 | Inhibitor | 98.16% | Unkown |
| HY-32018 | Cot inhibitor-2 | Inhibitor | 99.65% | Unkown |
| HY-W082785A | L6H21 | 99.19% | Unkown | |
| HY-103435 | Vialinin A | 99.90% | Unkown | |
| HY-108518 | SB-772077B dihydrochloride | Inhibitor | 99.33% | Unkown |
| HY-12326B | c-di-AMP diammonium | Agonist | 99.01% | Unkown |
| HY-124339 | JNJ525 | Inhibitor | 99.93% | Unkown |
| HY-N0442 | 5-O-Methylvisammioside | Inhibitor | 99.90% | Unkown |
| HY-N2350 | Cynaropicrin | Inhibitor | 99.79% | Unkown |
| HY-N6246 | Asperulosidic Acid | Inhibitor | 99.63% | Unkown |
| HY-P1875 | TNF-α (46-65), human | 98.68% | Unkown | |
| HY-W026772 | Fluorene | 99.35% | Unkown | |
| HY-124750 | NecroX-7 | Inhibitor | 99.69% | Unkown |
| HY-152956 | STING agonist-23 | Agonist | 99.33% | Unkown |
| HY-N0613 | Sauchinone | Inhibitor | 99.62% | Unkown |
| HY-N0626A | Potassium sorbate | Inhibitor | 98.0% | Unkown |
| HY-N1482 | Methyl palmitate | 98.0% | Unkown | |
| HY-N2055 | Kaempferol 3-O-sophoroside | 99.41% | Unkown | |
| HY-W1000105 | Geranial | 99.51% | Unkown | |
| HY-N0617 | Sanggenon C | 98.46% | Unkown | |
| HY-N0924 | (±)-Stylopine | Inhibitor | 99.86% | Unkown |
| HY-N4285 | Negletein | 99.55% | Unkown | |
| HY-P10086 | TREM-1 inhibitory peptide GF9 | Inhibitor | 99.41% | Unkown |
| HY-171034 | PQA-18 | Inhibitor | 99.62% | Unkown |
| HY-135674 | SR-318 | Inhibitor | 98.17% | Unkown |
| HY-125740 | Malvidin-3-glucoside chloride | Inhibitor | 99.87% | Unkown |
| HY-N0631 | Cornuside | Inhibitor | 99.99% | Unkown |
| HY-N0695 | Schisantherin B | 99.75% | Unkown | |
| HY-N2374 | Eupatorin | Inhibitor | 99.53% | Unkown |
| HY-N4205 | Tetrahydropiperine | Inhibitor | 99.41% | Unkown |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-N6983 | Licoricesaponin G2 | 99.87% | Unkown | |
| HY-169118 | EGR-1-IN-2 | Inhibitor | 99.61% | Unkown |
| HY-106381 | Aurothiomalate sodium | Inhibitor | 98.0% | Unkown |
| HY-113440 | 5-Methoxytryptophol | 99.95% | Unkown | |
| HY-N5084 | Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside | 98.92% | Unkown | |
| HY-P1847A | IKKγ NBD Inhibitory Peptide TFA | 98.77% | Unkown | |
| HY-10320A | Doramapimod hydrochloride | Inhibitor | 98.29% | Unkown |
| HY-N15135 | Arabinoxylan (Medium viscosity) | 95.0% | Unkown | |
| HY-104073 | CAY10602 | Activator | 98.69% | Unkown |
| HY-114243 | DpC | 98.73% | Unkown | |
| HY-139066 | Punicic acid | 98.5% | Unkown | |
| HY-B2162D | Chondroitin sulfate (from chicken) | Inhibitor | 99.61% | Unkown |
| HY-N0637A | (±)-Eriodictyol | Inhibitor | 99.9% | Unkown |
| HY-N0906 | Ginsenoside Rk3 | Inhibitor | 99.79% | Unkown |
| HY-N1356 | Reticuline | Inhibitor | 98.89% | Unkown |
| HY-N1921 | Edpetiline | Inhibitor | 99.81% | Unkown |
| HY-N2086 | Ethyl palmitate | Inhibitor | 99.09% | Unkown |
| HY-N4323 | 14-Deoxyandrographolide | Inhibitor | 99.94% | Unkown |
| HY-156025 | HCAR2 agonist 1 | Agonist | 99.11% | Unkown |
| HY-116626 | SM-7368 | Inhibitor | 99.77% | Unkown |
| HY-123936 | SR12343 | Inhibitor | 99.66% | Unkown |
| HY-123984 | LTβR-IN-1 | Activator | 99.79% | Unkown |
| HY-12511 | SKF-86002 | Inhibitor | 99.91% | Unkown |
| HY-147105 | LRH-1 agonist-2 | 98.58% | Unkown | |
| HY-153598 | LD4172 | 98.32% | Unkown | |
| HY-20070 | BMS-566394 | Inhibitor | 99.95% | Unkown |
| HY-N0863 | Methyl protodioscin | 99.67% | Unkown | |
| HY-N0902 | Dihydrosanguinarine | Inhibitor | 99.98% | Unkown |
| HY-N0920 | Dihydrokavain | Inhibitor | 99.94% | Unkown |
| HY-N2263 | Skimmin | 99.64% | Unkown | |
| HY-N4124 | Poricoic acid B | Inhibitor | 98.60% | Unkown |
| HY-N6857 | Armepavine | Inhibitor | 99.53% | Unkown |
| HY-157325 | RIPK2-IN-5 | Inhibitor | 99.73% | Unkown |
| HY-141582 | Ceramide 3 | Inhibitor | 98.0% | Unkown |
| HY-N0506 | Rosarin | 99.96% | Unkown | |
| HY-N2368 | Arecaidine | 99.63% | Unkown | |
| HY-N3031 | Grosvenorine | 99.64% | Unkown | |
| HY-N7056 | 4'-Hydroxychalcone | Inhibitor | 99.66% | Unkown |
| HY-P2612A | WP9QY TFA | Antagonist | 99.44% | Unkown |
| HY-W753791 | (±)-Perillaldehyde | 96.70% | Unkown | |
| HY-102040 | Hispidol | Inhibitor | 98.30% | Unkown |
| HY-128348 | PK68 | Inhibitor | 99.92% | Unkown |
| HY-112275 | TNF-α-IN-1 | Inhibitor | 99.20% | Unkown |
| HY-113953 | Z-Asp-CH2-DCB | Inhibitor | 99.64% | Unkown |
| HY-142069 | KB-R7785 | Inhibitor | 99.90% | Unkown |
| HY-N0907 | Ginsenoside Rg6 | 99.87% | Unkown | |
| HY-N3807 | Enniatin B1 | Inhibitor | 99.34% | Unkown |
| HY-N7627 | Regaloside C | 99.62% | Unkown | |
| HY-W668775 | Quin-C7 | Antagonist | 99.76% | Unkown |
| HY-W722277A | LCC-12 formate | Inhibitor | 99.90% | Unkown |
| HY-123194 | SIRT2/6-IN-1 | Inhibitor | 99.79% | Unkown |
| HY-N2736 | 3′,4′,7-Trihydroxyflavone | Inhibitor | 99.04% | Unkown |
| HY-13740S | Resiquimod-d5 | 98.33% | Unkown | |
| HY-147506 | NOD2 antagonist 1 | 99.57% | Unkown | |
| HY-159884 | MG-T-19 | 98.34% | Unkown | |
| HY-168894 | CT-1 | 99.90% | Unkown | |
| HY-173425 | STING-IN-15 | Inhibitor | 99.04% | Unkown |
| HY-N0358 | 1,4-Dicaffeoylquinic acid | Inhibitor | 99.25% | Unkown |
| HY-P2612 | WP9QY | 99.79% | Unkown | |
| HY-P3585 | Epobis | Inhibitor | 99.38% | Unkown |
| HY-W013675 | 2-Methoxyhydroquinone | Pre-designed Set | 99.57% | Unkown |
| HY-W015515 | L-Citronellol | Inhibitor | 99.92% | Unkown |
| HY-130252 | YQ128 | Inhibitor | 99.74% | Unkown |
| HY-150612 | (R)-STU104 | Inhibitor | 99.91% | Unkown |
| HY-106381A | Aurothiomalate tetramer sodium | Inhibitor | 98.0% | Unkown |
| HY-112456 | IKK2-IN-4 | Inhibitor | 99.36% | Unkown |
| HY-112642 | 9-Methoxycanthin-6-one | Inhibitor | 99.80% | Unkown |
| HY-118922 | IW927 | Inhibitor | 99.23% | Unkown |
| HY-129113 | α-Chaconine | Inhibitor | 99.76% | Unkown |
| HY-131945 | CU-115 | Antagonist | 99.63% | Unkown |
| HY-14562 | TBPB | 99.74% | Unkown | |
| HY-145726A | ISIS 104838 sodium | Inhibitor | 96.37% | Unkown |
| HY-155830 | Morcamilast | Inhibitor | 98.92% | Unkown |
| HY-170415 | EGR-1-IN-3 | Inhibitor | 99.13% | Unkown |
| HY-N1987 | Cucurbitacin IIb | Inducer | 99.74% | Unkown |
| HY-N3316 | Martynoside | 99.41% | Unkown | |
| HY-N4288 | 4-Methylesculetin | Inhibitor | 99.27% | Unkown |
| HY-N6017 | Bakkenolide A | 99.99% | Unkown | |
| HY-N7926 | Pentadecane | 98.88% | Unkown | |
| HY-P1825A | TNF-α (10-36), human TFA | 98.23% | Unkown | |
| HY-P1860A | TNF-α (31-45), human TFA | 99.40% | Unkown | |
| HY-P4744 | LL-37 amide | Inhibitor | 99.77% | Unkown |
| HY-P6442 | Chemerin15 | 99.65% | Unkown | |
| HY-W923189 | Neral | 97.87% | Unkown | |
| HY-W002199 | 6:2 Fluorotelomer alcohol | 99.96% | Unkown | |
| HY-12326 | c-di-AMP | Agonist | 99.29% | Unkown |
| HY-139617 | Sec61-IN-3 | Inhibitor | 99.22% | Unkown |
| HY-112389 | p38 MAP Kinase Inhibitor III | Inhibitor | 98.77% | Unkown |
| HY-116392F | D-threo-PDMP hydrochloride | Inhibitor | 98.0% | Unkown |
| HY-121435 | K-8012 | 99.51% | Unkown | |
| HY-125527S | Resolvin D1-d5 | 99.2% | Unkown | |
| HY-134911 | HS-243 | Inhibitor | 99.95% | Unkown |
| HY-147696 | SMTIN-T140 | 99.54% | Unkown | |
| HY-152959 | STING agonist-26 | Agonist | 99.56% | Unkown |
| HY-172458 | Z-3578 | Inhibitor | 98.72% | Unkown |
| HY-174138 | NF-κB degrader 1 | Degrader | 99.92% | Unkown |
| HY-175479 | GLPG4970 | 99.60% | Unkown | |
| HY-N0412 | Sesamoside | Inhibitor | 99.77% | Unkown |
| HY-N0887 | Isoastragaloside I | 99.49% | Unkown | |
| HY-N12717 | Casuarinin | 98.24% | Unkown | |
| HY-N1940 | β-Anhydroicaritin | Inhibitor | 99.69% | Unkown |
| HY-N2082 | Isorhamnetin 3-O-galactoside | Inhibitor | 99.64% | Unkown |
| HY-N7064 | Iminostilbene | Inhibitor | 99.34% | Unkown |
| HY-N9315 | Episappanol | Inhibitor | 98.80% | Unkown |
| HY-D1056C1 | Lipopolysaccharides, from S. enterica serotype enteritidis | Activator | / | Unkown |
| HY-139616 | Sec61-IN-2 | Inhibitor | 99.51% | Unkown |
| HY-162359 | BIO-7488 | Inhibitor | 99.44% | Unkown |
| HY-118157 | 3,5,7-Trimethoxyflavone | Inhibitor | 98.86% | Unkown |
| HY-124686 | ER-464195-01 | Inhibitor | 99.72% | Unkown |
| HY-145498 | HDMAPP triammonium | Activator | 90.0% | Unkown |
| HY-145885 | TLR7/8 agonist 6 | 98.93% | Unkown | |
| HY-14622B | Necrostatin 2 (S enantiomer) | Inhibitor | 99.76% | Unkown |
| HY-146765 | AMS-17 | Inhibitor | 98.09% | Unkown |
| HY-147078 | EJMC-1 | Inhibitor | 99.39% | Unkown |
| HY-151966 | TD1092 | 99.49% | Unkown | |
| HY-160231 | ssRNA42 sodium | Activator | 98.62% | Unkown |
| HY-164102 | TNF-α-IN-18 | Inhibitor | 98.94% | Unkown |
| HY-170495 | HDAC6 degrader-5 | Inhibitor | 99.55% | Unkown |
| HY-179715 | PROTAC JAK1/2 degrader-1 | 99.47% | Unkown | |
| HY-N0569R | Madecassic acid (Standard) | Inhibitor | 99.91% | Unkown |
| HY-N2252 | Licarin A | Inhibitor | 99.83% | Unkown |
| HY-N6927 | Isoforskolin | Inhibitor | 98.0% | Unkown |
| HY-N7259 | (+)-Isomenthone | 99.13% | Unkown | |
| HY-P11107 | RP-832c | 99.86% | Unkown | |
| HY-P11108 | RP-182 | 98.68% | Unkown | |
| HY-P11296A | LLVK TFA | Inhibitor | 99.50% | Unkown |
| HY-125980 | LX-3 | Inhibitor | 98.08% | Unkown |
| HY-156060 | NCI126224 | Inhibitor | 99.77% | Unkown |
| HY-32015 | Cot inhibitor-1 | Inhibitor | 98.45% | Unkown |
| HY-N0854 | Alisol F | Inhibitor | 99.89% | Unkown |
| HY-N8593 | Undecane | 99.66% | Unkown | |
| HY-101041 | (E)-AG 556 | Inhibitor | 99.91% | Unkown |
| HY-101961 | Tyrphostin AG 1288 | Inhibitor | 98.68% | Unkown |
| HY-106359A | Delmitide acetate | Inhibitor | 99.22% | Yes |
| HY-114592 | M199 | 98.55% | Unkown | |
| HY-118828B | 12-Oxo phytodienoic acid (≥90%) | 92.2% | Unkown | |
| HY-121811 | Pongamol | 99.81% | Unkown | |
| HY-145726 | ISIS 104838 | Inhibitor | 91.02% | Unkown |
| HY-148454 | Necroptosis-IN-3 | Inhibitor | 99.53% | Unkown |
| HY-148908 | TNF-α-IN-8 | Inhibitor | 95.0% | Unkown |
| HY-156850 | ITF 3756 | 98.55% | Unkown | |
| HY-157456 | RIPK1-IN-19 | Inhibitor | 98.87% | Unkown |
| HY-160178 | Glucocorticoid receptor agonist-3 Ala-Ala-Mal | 99.70% | Unkown | |
| HY-172590 | LZ-07 | 98.27% | Unkown | |
| HY-174156 | Y2641 | Inhibitor | 98.31% | Unkown |
| HY-177338 | STING agonist-45 | Agonist | 99.10% | Unkown |
| HY-N10424 | Brazilein | 99.9% | Unkown | |
| HY-N14001 | Naamidine J | 99.41% | Unkown | |
| HY-N5073 | Vitexin-4''-O-glucoside | Inhibitor | 99.86% | Unkown |
| HY-N7905 | Myricetin 3'-glucoside | Inhibitor | 99.98% | Unkown |
| HY-124003 | Phytomonic acid | 99.33% | Unkown | |
| HY-B1272AS | Desipramine-d4 | 98.93% | Unkown | |
| HY-W013331 | Deoxyartemisinin | Inhibitor | 99.9% | Unkown |
| HY-W013557 | 3-Hydroxyxanthone | Inhibitor | 98.38% | Unkown |
| HY-W109613 | Methyl dehydroabietate | 99.89% | Unkown | |
| HY-12761 | A-836339 | Agonist | 99.84% | Unkown |
| HY-133807A | (Rac)-Benpyrine | Inhibitor | 99.30% | Unkown |
| HY-108623 | Atizoram | Inhibitor | 96.3% | Unkown |
| HY-111317 | SIRT1 activator 3 | Activator | 99.9% | Unkown |
| HY-114221 | Org 48762-0 | Inhibitor | 99.99% | Unkown |
| HY-120823 | PF-05381941 | Inhibitor | 99.73% | Unkown |
| HY-158990 | GE1111 | 95.73% | Unkown | |
| HY-169004 | CBT-295 | Inhibitor | 99.34% | Unkown |
| HY-169402 | PDE1-IN-9 | Inhibitor | / | Unkown |
| HY-169402A | PDE1-IN-9 hydrochloride | Inhibitor | / | Unkown |
| HY-170522 | ISM012-042 | Inhibitor | 98.69% | Unkown |
| HY-174066 | SI-W052 | 98.0% | Unkown | |
| HY-183326 | Isosorbide di-(methyl fumarate) | Activator | 99.87% | Unkown |
| HY-N2421 | Sequoyitol | 98.0% | Unkown | |
| HY-N2855 | Alphitolic acid | 97.0% | Unkown | |
| HY-N8371 | Shizukaol B | Inhibitor | 96.0% | Unkown |
| HY-P2320 | IDR-1 | Inhibitor | 99.01% | Unkown |
| HY-RS14784 | TNF Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W322573 | (R)-Ketoprofen | Inhibitor | 95.0% | Unkown |
| HY-114531 | Lomifylline | 99.67% | Unkown | |
| HY-134454 | Z-Pro-Pro-CHO | Inhibitor | 98.03% | Unkown |
| HY-137370 | 2-Hexynyl-5′-N-ethylcarboxamidoadenosine | 99.39% | Unkown | |
| HY-N4308 | Hexamethylquercetagetin | Inhibitor | 98.0% | Unkown |
| HY-W013636C | 2-Ketoglutaric acid potassium | Inhibitor | 98.0% | Unkown |
| HY-W026772S1 | Fluorene-d8 | / | Unkown | |
| HY-178054 | LMDP10 | Activator | 99.91% | Unkown |
| HY-131707 | LEO 39652 | Inhibitor | 99.51% | Unkown |
| HY-145961 | TLR7 agonist 4 | 98.87% | Unkown | |
| HY-110246 | Quin C1 | Agonist | 98.47% | Unkown |
| HY-116392E | D-threo-PDMP | Inhibitor | 99.50% | Unkown |
| HY-116678A | Cloricromen hydrochloride | Inhibitor | 99.82% | Unkown |
| HY-117082 | UTL-5g | Inhibitor | 99.92% | Unkown |
| HY-12085S | Apremilast-d5 | 99.26% | Unkown | |
| HY-121309 | Doxorubicinone | Inhibitor | 98.29% | Unkown |
| HY-121996 | Prostaglandin E2 Ethanolamide | / | Unkown | |
| HY-122786 | 3-O-Methylviridicatin | Inhibitor | / | Unkown |
| HY-129151 | Ganoderic acid C1 | Inhibitor | 95% | Unkown |
| HY-133807B | (R)-Benpyrine | Control | 99.08% | Unkown |
| HY-135808 | BIZ 114 | Inhibitor | 98.0% | Unkown |
| HY-147086 | CAY10789 | 99.84% | Unkown | |
| HY-150612S | (R)-STU104-d6 | 99.90% | Unkown | |
| HY-150729 | ODN 1982 | Inhibitor | / | Unkown |
| HY-150729A | ODN 1982 sodium | 99.04% | Unkown | |
| HY-151369 | AV123 | Inhibitor | 99.60% | Unkown |
| HY-151876 | Glucocorticoid receptor modulator 1 | 99.79% | Unkown | |
| HY-153579 | Anti-inflammatory agent 42 | Inhibitor | 98.0% | Unkown |
| HY-157992 | LM-021 | Inhibitor | 98.27% | Unkown |
| HY-160179 | Glucocorticoid receptor agonist-4 | Agonist | 99.80% | Unkown |
| HY-161016 | TNF/IFN-γ-IN-1 | Inhibitor | 99.39% | Unkown |
| HY-161901 | BC-1293 | Inhibitor | 98.40% | Unkown |
| HY-162649 | TIC10g | Inhibitor | 98.92% | Unkown |
| HY-173462 | TBK1-IN-2 | Inhibitor | 98.19% | Unkown |
| HY-176192 | SMU-14a | Inhibitor | / | Unkown |
| HY-177515 | IRAK4 modulator-2 | Inhibitor | 99.86% | Unkown |
| HY-178041 | BRD4-BD1/2-IN-3 | Inhibitor | 99.52% | Unkown |
| HY-179421 | PROTAC HDAC6 degrader 7 | Inhibitor | / | Unkown |
| HY-182644 | SMU-Z1 | / | Unkown | |
| HY-18754A | FR 167653 | Inhibitor | 99.87% | Unkown |
| HY-D3381 | MitoCLox | 99.59% | Unkown | |
| HY-N0619A | cis-Mulberroside A | Inhibitor | ≥96.0% | Unkown |
| HY-N0626AR | Potassium sorbate (Standard) | Inhibitor | 99.99% | Unkown |
| HY-N0811 | Anemarsaponin B | Inhibitor | 99.43% | Unkown |
| HY-N11768 | 4-Methoxylonchocarpin | Inhibitor | 98.0% | Unkown |
| HY-N3595 | Cleomiscosin A | Inhibitor | 99.15% | Unkown |
| HY-N4267 | Yangambin | 98.27% | Unkown | |
| HY-N7183 | 9-Hydroxycanthin-6-one | / | Unkown | |
| HY-N7926S | Pentadecane-d32 | 99.2% | Unkown | |
| HY-N8413 | Chlojaponilactone B | Inhibitor | 98.0% | Unkown |
| HY-N9867 | Gnetifolin E | Inhibitor | 97% | Unkown |
| HY-P11108A | RP-182 acetate | / | Unkown | |
| HY-P1875A | TNF-α (46-65), human TFA | 99.90% | Unkown | |
| HY-P3149B | LEESGGGLVQPGGSMK acetate | 99.01% | Unkown | |
| HY-P3203A | DSTYSLSSTLTLSK TFA | 98.44% | Unkown | |
| HY-RS14785 | Tnf Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010201R | Citronellol (Standard) | 97.16% | Unkown | |
| HY-W342283 | Diminazene | / | Unkown | |
| HY-120152A | SLP7111228 hydrochloride | Inhibitor | 98.01% | Unkown |
| HY-123115 | Leucrose | 98.53% | Unkown | |
| HY-141582S | Ceramide 3-d3 | Inhibitor | 98.0% | Unkown |
| HY-150219A | ODN M326 sodium | Inhibitor | / | Unkown |
| HY-152169 | BIHC | ≥98.0% | Unkown | |
| HY-154792 | Pyrrolidone carboxylic acid | / | Unkown | |
| HY-158650 | 10-OAHSA | Inhibitor | 99.0% | Unkown |
| HY-163642 | TNF-α agonistic 1 | 98.37% | Unkown | |
| HY-171591 | SIK2-IN-4 | Inhibitor | 99.06% | Unkown |
| HY-174736 | Human CD70 mRNA | 90% | Unkown | |
| HY-N0626R | Sorbic acid (Standard) | Inhibitor | 99.98% | Unkown |
| HY-N11011 | Withaphysalin A | Inhibitor | 98% | Unkown |
| HY-N13184 | Giraldoid B | Inhibitor | 98.49% | Unkown |
| HY-N15936 | a15:0-i15:0 PE | / | Unkown | |
| HY-W030338 | aPKC-IN-2 | 99.80% | Unkown | |
| HY-W041608 | Methylchloroisothiazolinone | / | Unkown | |
| HY-131340 | LASSBio-1632 | Inhibitor | / | Unkown |
| HY-132195 | RORγt inverse agonist 14 | Inhibitor | / | Unkown |
| HY-19667 | BMS-561392 | / | Unkown | |
| HY-114243A | DpC hydrochloride | / | Unkown | |
| HY-183934 | Anti-inflammatory agent 99 | Inhibitor | / | Unkown |
| HY-B1272AS1 | Desipramine-d3 | / | Unkown | |
| HY-W013150S | Alpidem-d14 | / | Unkown | |
| HY-100211A | (R)-TAPI-2 | Control | / | Unkown |
| HY-100485 | Susalimod | / | Unkown | |
| HY-100607S | Landiolol-d8 | / | Unkown | |
| HY-100702 | SH-5 | / | Unkown | |
| HY-101410A | SDMA (p-hydroxyazobenzene-p′-sulfonate) | / | Unkown | |
| HY-10406B | rel-Talmapimod hydrochloride | / | Unkown | |
| HY-105188A | ONO-4007 | Inducer | / | Unkown |
| HY-105480 | SKF 104351 | Inhibitor | / | Unkown |
| HY-105488 | MDL 201112 | Inhibitor | / | Unkown |
| HY-106359 | Delmitide | Inhibitor | / | Unkown |
| HY-107272 | Chuanbeinone | / | Unkown | |
| HY-107338 | Denotivir | Inhibitor | / | Unkown |
| HY-107737S | 1,2-DLPC-d55 | / | Unkown | |
| HY-107737S2 | 1,2-DLPC-d46 | / | Unkown | |
| HY-107737S3 | 1,2-DLPC-d9 | / | Unkown | |
| HY-108162A | Ataquimast | Inhibitor | / | Unkown |
| HY-108641 | SKF-86002 dihydrochloride | Inhibitor | / | Unkown |
| HY-108642A | AMG-548 hydrochloride | Inhibitor | / | Unkown |
| HY-108953 | (S)-Quinolactacine A | Inhibitor | / | Unkown |
| HY-112369 | LDDN-0003499 | / | Unkown | |
| HY-112481 | IKK2-IN-5 | / | Unkown | |
| HY-112904A | XRK3F2 free base | Inhibitor | / | Unkown |
| HY-113898 | Ganoderic acid K | Inhibitor | / | Unkown |
| HY-114159 | GGTI-2166 | Inhibitor | / | Unkown |
| HY-114573 | TNF-α-IN-19 | Inhibitor | / | Unkown |
| HY-114908 | CX-659S | Inhibitor | / | Unkown |
| HY-114980 | BMS-279700 | Inhibitor | / | Unkown |
| HY-114981 | SRTCX1002 | Activator | / | Unkown |
| HY-115351 | GW-3333 | Inhibitor | / | Unkown |
| HY-115913 | PDE4-IN-6 | Inhibitor | / | Unkown |
| HY-115976 | COX-2-IN-10 | Inhibitor | / | Unkown |
| HY-116678 | Cloricromen | Inhibitor | / | Unkown |
| HY-117356A | MRS2693 ammonium | / | Unkown | |
| HY-117569 | KF24345 free base | Inhibitor | / | Unkown |
| HY-118101 | 15-Deoxy-Δ12,14-prostaglandin A1 | / | Unkown | |
| HY-118316 | GSK223 | Inhibitor | / | Unkown |
| HY-118646 | NS-6740 | / | Unkown | |
| HY-118646A | NS-6740 hydrochloride | / | Unkown | |
| HY-119298 | AW-814141 | Inhibitor | / | Unkown |
| HY-120041 | ND-2158 | Inhibitor | / | Unkown |
| HY-120152 | SLP7111228 | Inhibitor | / | Unkown |
| HY-120269 | CAY10512 | Inhibitor | 97.0% | Unkown |
| HY-120600 | Sibiriline | Inhibitor | / | Unkown |
| HY-12085S3 | Apremilast-d3 | / | Unkown | |
| HY-121401 | Myrtenal | / | Unkown | |
| HY-122292 | Celastramycin A | Inhibitor | / | Unkown |
| HY-122521 | Sootepin D | Inhibitor | / | Unkown |
| HY-122566 | SMU127 | / | Unkown | |
| HY-123542 | ONO-3403 | / | Unkown | |
| HY-123670 | RPR-200765A methanesulfonate | Inhibitor | / | Unkown |
| HY-123736 | Ro 32-7315 | Inhibitor | / | Unkown |
| HY-123882 | IRAK4-IN-29 | / | Unkown | |
| HY-124388 | PDE4-IN-20 | / | Unkown | |
| HY-124665 | LMP-420 | / | Unkown | |
| HY-124954 | MN-25 | Agonist | / | Unkown |
| HY-126026 | NF-κB-IN-17 | Inhibitor | / | Unkown |
| HY-126232 | Verproside | / | Unkown | |
| HY-126414 | Methylenedihydrotanshinquinone | / | Unkown | |
| HY-128423AS | Tylvalosin-d9 | / | Unkown | |
| HY-129684 | IAXO-101 iodide | Inhibitor | / | Unkown |
| HY-131675 | CH-100 | / | Unkown | |
| HY-134028 | Arucadiol | Inhibitor | / | Unkown |
| HY-13478 | AS1940477 | Inhibitor | / | Unkown |
| HY-134950 | (E)-C-HDMAPP ammonium | Activator | / | Unkown |
| HY-136010 | RIP2 Kinase Inhibitor 4 | Inhibitor | / | Unkown |
| HY-138623 | GSK789 | Inhibitor | / | Unkown |
| HY-141439 | TBE 31 | / | Unkown | |
| HY-142958 | NF-κB-IN-2 | / | Unkown | |
| HY-14305 | BMS-582949 | / | Unkown | |
| HY-143410 | Anti-inflammatory agent 16 | Inhibitor | / | Unkown |
| HY-144368 | CO delivery molecule 1 | Inhibitor | / | Unkown |
| HY-144727 | Anti-inflammatory agent 11 | Inhibitor | / | Unkown |
| HY-144737 | Anti-inflammatory agent 15 | Inhibitor | / | Unkown |
| HY-145492 | Δ7(Z)-C14-HSL | / | Unkown | |
| HY-145886 | TLR7/8 antagonist 1 | / | Unkown | |
| HY-146419 | Anti-inflammatory agent 20 | Inhibitor | / | Unkown |
| HY-146435 | Anti-inflammatory agent 22 | Inhibitor | / | Unkown |
| HY-146483 | Anti-Aβ agent 1A | Inhibitor | / | Unkown |
| HY-146547 | Anti-inflammatory agent 17 | Inhibitor | / | Unkown |
| HY-146723 | IKKβ-IN-1 | Inhibitor | / | Unkown |
| HY-147141A | HS-276 hydrochloride | Inhibitor | / | Unkown |
| HY-147141B | HS-276 formic | Inhibitor | / | Unkown |
| HY-147697 | LSD1-IN-21 | Inhibitor | / | Unkown |
| HY-147712 | PKC-IN-4 | Inhibitor | / | Unkown |
| HY-147924 | Keap1-Nrf2-IN-11 | Inhibitor | / | Unkown |
| HY-147950 | PDE4-IN-10 | Inhibitor | / | Unkown |
| HY-148606 | STING modulator-3 | Inhibitor | / | Unkown |
| HY-149151 | Variegatic acid | Inhibitor | / | Unkown |
| HY-149331 | TNF-α-IN-11 | Inhibitor | / | Unkown |
| HY-149485 | JNK2-IN-1 | Inhibitor | / | Unkown |
| HY-149816 | Anti-inflammatory agent 41 | Inhibitor | / | Unkown |
| HY-149984 | MAO-B-IN-21 | Inhibitor | / | Unkown |
| HY-150219 | ODN M326 | Agonist | / | Unkown |
| HY-150725A | Biotin-labeled ODN 1585 sodium | / | Unkown | |
| HY-150725B | FITC-labeled ODN 1585 sodium | Inducer | / | Unkown |
| HY-151188 | DHU-Se1 | Inhibitor | / | Unkown |
| HY-152213 | BET-IN-13 | Inhibitor | / | Unkown |
| HY-152957 | STING agonist-24 | Agonist | / | Unkown |
| HY-152958 | STING agonist-25 | Agonist | / | Unkown |
| HY-152961 | STING agonist-28 | Agonist | / | Unkown |
| HY-153329 | TNF-α-IN-9 | Inhibitor | / | Unkown |
| HY-153330 | TNF-α-IN-10 | Inhibitor | / | Unkown |
| HY-153504 | TACE-IN-1 | Inhibitor | / | Unkown |
| HY-153952 | Immuno modulator-1 | Inhibitor | / | Unkown |
| HY-154698 | Homouridine | / | Unkown | |
| HY-155027 | DPP-4-IN-8 | Inhibitor | / | Unkown |
| HY-15509 | Semapimod | Inhibitor | / | Unkown |
| HY-155179 | ZMF-23 | Inhibitor | / | Unkown |
| HY-155199 | PDE1-IN-5 | Inhibitor | / | Unkown |
| HY-155243 | 12R-LOX-IN-1 | Inhibitor | / | Unkown |
| HY-155405 | Anti-inflammatory agent 64 | Inhibitor | / | Unkown |
| HY-155753 | Anti-inflammatory agent 50 | Inhibitor | / | Unkown |
| HY-155759 | HMGB1-IN-2 | Inhibitor | / | Unkown |
| HY-155820 | Anti-inflammatory agent 54 | Inhibitor | / | Unkown |
| HY-155821 | Anti-inflammatory agent 55 | Inhibitor | / | Unkown |
| HY-15616 | BMS-470539 | Agonist | / | Unkown |
| HY-156367 | RIPK1-IN-16 | Inhibitor | / | Unkown |
| HY-157546 | VEGFR-2-IN-40 | Inhibitor | / | Unkown |
| HY-157809 | Anti-inflammatory agent 74 | Inhibitor | / | Unkown |
| HY-158036 | PROTAC STING Degrader-2 | / | Unkown | |
| HY-159100 | PVP-037 | Agonist | / | Unkown |
| HY-159516 | Sabialimon P | Inhibitor | / | Unkown |
| HY-159669 | Stercobilin hydrochloride (mixture of isomers) | Inhibitor | / | Unkown |
| HY-159891 | Microtubule destabilizing agent-2 | / | Unkown | |
| HY-159938 | p38α inhibitor 6 | / | Unkown | |
| HY-160027 | TNF-alpha-IN-1 | Inhibitor | / | Unkown |
| HY-160180 | Glucocorticoid receptor agonist-4 Ala-Ala-Mal | / | Unkown | |
| HY-160433 | TNF-α-IN-12 | Inhibitor | / | Unkown |
| HY-160434 | TNF-α-IN-13 | Inhibitor | / | Unkown |
| HY-160435 | TNF-α-IN-14 | Inhibitor | / | Unkown |
| HY-160436 | TNF-α-IN-15 | Inhibitor | / | Unkown |
| HY-160437 | TNF-α-IN-16 | Inhibitor | / | Unkown |
| HY-160844 | CT-133 | / | Unkown | |
| HY-161240 | MAO-B-IN-30 | Inhibitor | 98.53% | Unkown |
| HY-161381 | PDE4-IN-15 | Inhibitor | / | Unkown |
| HY-161520 | Glucocorticoid receptor/NF-κB modulator-1 | / | Unkown | |
| HY-161620 | DW18134 | Inhibitor | / | Unkown |
| HY-161629 | TLR8 agonist 7 | Agonist | / | Unkown |
| HY-161630 | TLR8 agonist 8 | Agonist | / | Unkown |
| HY-161631 | TLR8 agonist 9 | Agonist | / | Unkown |
| HY-161674 | Monoamine Oxidase B inhibitor 4 | Inhibitor | / | Unkown |
| HY-161757 | Anti-inflammatory agent 86 | / | Unkown | |
| HY-161833 | HSP90-IN-31 | Inhibitor | / | Unkown |
| HY-161936 | Z21115 | Inhibitor | / | Unkown |
| HY-161991 | Caspase-3 activator 4 | / | Unkown | |
| HY-162097 | RIPK1-IN-20 | Inhibitor | / | Unkown |
| HY-162116 | TLR7 agonist 18 | Agonist | / | Unkown |
| HY-162316 | NF-κB-IN-15 | Inhibitor | / | Unkown |
| HY-162599 | Spirohypertone B | Inhibitor | / | Unkown |
| HY-162600 | CDK8-IN-15 | Inhibitor | / | Unkown |
| HY-162641 | AF-45 | Inhibitor | / | Unkown |
| HY-162797 | PDE4-IN-18 | Inhibitor | / | Unkown |
| HY-162844 | CDN-3 | Activator | / | Unkown |
| HY-162850 | DOR agonist 2 | / | Unkown | |
| HY-162861 | 3-Methyl-chuangxinmycin | Inhibitor | / | Unkown |
| HY-163280 | JGB-1-155 | Activator | / | Unkown |
| HY-163368 | HDAC6-IN-34 | Inhibitor | / | Unkown |
| HY-16362 | Omtriptolide sodium | / | Unkown | |
| HY-163670 | TLR7 agonist 21 | Inhibitor | / | Unkown |
| HY-163673 | Glucocorticoid receptor modulator 4 | Modulator | / | Unkown |
| HY-163712S | 17-Epiestriol-d5-1 | / | Unkown | |
| HY-163747 | VEGFR-2-IN-47 | Inhibitor | / | Unkown |
| HY-163748 | GSK-3β inhibitor 17 | Inhibitor | / | Unkown |
| HY-163755 | GPER activator 1 | / | Unkown | |
| HY-163777 | Talaroterphenyl A | Inhibitor | / | Unkown |
| HY-163998 | TLR4-IN-1 | / | Unkown | |
| HY-167877 | PS-166276 | Inhibitor | / | Unkown |
| HY-168130 | TNF-α/IL-1β-IN-1 | Inhibitor | / | Unkown |
| HY-168340 | COX-2/15-LOX-IN-6 | Inhibitor | / | Unkown |
| HY-168466 | Anti-neuroinflammation agent 2 | Inhibitor | / | Unkown |
| HY-168482 | NF-κB/MAPK-IN-2 | Inhibitor | / | Unkown |
| HY-168734 | CB2 receptor agonist 9 | Agonist | / | Unkown |
| HY-168935 | Anti-inflammatory agent 95 | Inhibitor | / | Unkown |
| HY-168971 | Paeoniflorin-6′-O-benzene sulfonate | / | Unkown | |
| HY-169103 | Neuroprotective agent 5 | Inhibitor | / | Unkown |
| HY-170218 | NLRP3-IN-76 | Inhibitor | / | Unkown |
| HY-170232 | RIPK1-IN-29 | Inhibitor | / | Unkown |
| HY-170492 | sEH inhibitor-19 | / | Unkown | |
| HY-170586 | JAK05 | / | Unkown | |
| HY-170723 | JAK-IN-39 | Inhibitor | / | Unkown |
| HY-171468 | CC-1069 | Inhibitor | / | Unkown |
| HY-171592 | RIPK2-IN-7 | Inhibitor | / | Unkown |
| HY-171780 | ASP9831 | Inhibitor | / | Unkown |
| HY-171837A | t9,t11,c15-CLNA | / | Unkown | |
| HY-171895 | 12-Nitrolinoleate | / | Unkown | |
| HY-171906A | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium | Inhibitor | / | Unkown |
| HY-172111 | EGFR-IN-144 | / | Unkown | |
| HY-172406 | MAPK-IN-4 | / | Unkown | |
| HY-172409 | CB1R antagonist 2 | / | Unkown | |
| HY-172430S | Epaldeudomide | Antagonist | / | Unkown |
| HY-172533 | 3′,5′-DiOA-dC | Agonist | / | Unkown |
| HY-172608 | TNF-α-IN-24 | Inhibitor | / | Unkown |
| HY-172619 | BS-153 | Inhibitor | / | Unkown |
| HY-172792 | PPAR agonist 6 | Agonist | / | Unkown |
| HY-172870 | PDE4B-IN-4 | Inhibitor | / | Unkown |
| HY-172871 | Anti-inflammatory agent 102 | Inhibitor | / | Unkown |
| HY-172977 | FGA139 | Inhibitor | / | Unkown |
| HY-173115 | 15-LOX-IN-2 | / | Unkown | |
| HY-173144 | AChE-IN-85 | Inhibitor | / | Unkown |
| HY-173180 | 5-LOX-IN-8 | Inhibitor | / | Unkown |
| HY-173187 | Keap1-Nrf2-IN-27 | Inhibitor | / | Unkown |
| HY-173210 | TNF-α-IN-22 | / | Unkown | |
| HY-173224 | CDK2/PIM1-IN-1 | Inhibitor | / | Unkown |
| HY-173294 | NLRP3-IN-74 | Inhibitor | / | Unkown |
| HY-173334 | hMAO-B-IN-11 | Inhibitor | / | Unkown |
| HY-173404 | VB-85247 | / | Unkown | |
| HY-173407 | P2Y14R antagonist 4 | / | Unkown | |
| HY-173410 | iNOs-IN-6 | Inhibitor | / | Unkown |
| HY-173416 | Anti-inflammatory agent 100 | Inhibitor | / | Unkown |
| HY-174144 | RJG-2036 | Inhibitor | / | Unkown |
| HY-174405 | PROTAC PDE4 degrader-1 | / | Unkown | |
| HY-174825 | TRPM8 antagonist 4 | / | Unkown | |
| HY-175007 | RIPK1-IN-32 | Inhibitor | / | Unkown |
| HY-175013 | CDK6/9-IN-2 | / | Unkown | |
| HY-175026 | RIPK2-IN-8 | / | Unkown | |
| HY-175182 | IDO1-IN-27 | Inhibitor | / | Unkown |
| HY-175250 | TNF-α-IN-25 | Inhibitor | / | Unkown |
| HY-175293 | SMU-C68 | / | Unkown | |
| HY-175430 | TNF-α-IN-26 | Inhibitor | / | Unkown |
| HY-175445 | GNE-5472 | / | Unkown | |
| HY-175446 | GDC-0152-acetamide | / | Unkown | |
| HY-175640 | Troponin-IN-1 | Inhibitor | / | Unkown |
| HY-175655 | BChE/p38-α MAPK-IN-1 | Inhibitor | / | Unkown |
| HY-175780 | CD28-IN-1 | Inhibitor | / | Unkown |
| HY-175782 | SMU-R39 | / | Unkown | |
| HY-175813 | NPSR1 antagonist-1 | / | Unkown | |
| HY-175833 | NF-κB-IN-20 | / | Unkown | |
| HY-176218 | TTTE | / | Unkown | |
| HY-176234 | PDE4-IN-28 | Inhibitor | / | Unkown |
| HY-176251 | CBP/p300-IN-22 | Inhibitor | / | Unkown |
| HY-176257 | STING agonist-44 | Agonist | / | Unkown |
| HY-176520 | PDE4-IN-29 | Inhibitor | / | Unkown |
| HY-176535 | KB-0118 | Inhibitor | / | Unkown |
| HY-176554 | sEH-IN-21 | Inhibitor | / | Unkown |
| HY-176882 | ASK1-IN-11 | Inhibitor | / | Unkown |
| HY-177155 | p38α-IN-10 | Inhibitor | / | Unkown |
| HY-177304 | Anti-inflammatory agent 104 | Inhibitor | / | Unkown |
| HY-177305 | Anti-inflammatory agent 105 | Inhibitor | / | Unkown |
| HY-177809 | aptTNF-α sodium | / | Unkown | |
| HY-178012 | GLPG4471 | Inhibitor | / | Unkown |
| HY-178053 | AHR agonist 10 | / | Unkown | |
| HY-178163 | Zharp1-163 | Inhibitor | / | Unkown |
| HY-178214 | CSBP ligand 1 | / | Unkown | |
| HY-178240 | rel-(1S,2R)-Dihydro bupropion | Inhibitor | / | Unkown |
| HY-178287 | TNF-α-IN-27 | Inhibitor | / | Unkown |
| HY-178302 | TNF-α agonistic 2 | / | Unkown | |
| HY-178353 | EGFR/Cytokine-IN-1 | / | Unkown | |
| HY-178356 | BChE-IN-44 | Inhibitor | / | Unkown |
| HY-178447 | PPARγ agonist 20 | / | Unkown | |
| HY-178497 | ZJK-807 | / | Unkown | |
| HY-178726 | Cot-IN-4 | Inhibitor | / | Unkown |
| HY-178762S | RIPK1-IN-35 | Inhibitor | / | Unkown |
| HY-178926 | RAGE406R | Inhibitor | / | Unkown |
| HY-178945 | KOR agonist 7 | / | Unkown | |
| HY-178950 | Hck-IN-3 | Inhibitor | / | Unkown |
| HY-178983 | SHP2-IN-45 | Inhibitor | / | Unkown |
| HY-179047 | SMU-L11-R | / | Unkown | |
| HY-179142 | COX-2-IN-60 | Inhibitor | / | Unkown |
| HY-179234 | LD5097 | / | Unkown | |
| HY-179336 | TLR7/8 agonist 14 | / | Unkown | |
| HY-179429 | NLRP3-IN-85 | Inhibitor | / | Unkown |
| HY-179432 | Cannabitwinol | / | Unkown | |
| HY-179502 | Anti-inflammatory agent 107 | / | Unkown | |
| HY-179503 | PDE/TRPA1/CHIT1-IN-1 | Inhibitor | / | Unkown |
| HY-179504 | PDE4B-IN-6 | Inhibitor | / | Unkown |
| HY-179517 | ASK1-IN-12 | Inhibitor | / | Unkown |
| HY-179646 | CIAC101 | / | Unkown | |
| HY-179701 | NIK-IN-3 | Inhibitor | / | Unkown |
| HY-180109 | Benzo-17R-RvD2 | Inhibitor | / | Unkown |
| HY-180165 | Antiallergic agent-5 | Inhibitor | / | Unkown |
| HY-180398 | PA-082 | Modulator | / | Unkown |
| HY-180579 | IRAK4-IN-33 | Inhibitor | / | Unkown |
| HY-180580 | SMU-C409 | / | Unkown | |
| HY-180608 | TCR-IN-1 | Inhibitor | / | Unkown |
| HY-180822 | COX-2-IN-63 | Inhibitor | / | Unkown |
| HY-181073 | Apoptosis/necroptosis inducer 1 | / | Unkown | |
| HY-181081 | CHNQD-03005 | Inhibitor | / | Unkown |
| HY-181124 | Idebenone-SS-20 | Inhibitor | / | Unkown |
| HY-181155 | Anti-inflammatory agent 111 | Inhibitor | / | Unkown |
| HY-181156 | Anti-inflammatory agent 112 | Inhibitor | / | Unkown |
| HY-181163 | Caspase-3/7 activator 4 | / | Unkown | |
| HY-181509 | TNF-α/IL-1β/IL-6-IN-1 | / | Unkown | |
| HY-181576 | ROCK2-IN-14 | Inhibitor | / | Unkown |
| HY-181612 | COX-2/CaV2.2-IN-1 | Inhibitor | / | Unkown |
| HY-181657 | EGFR-IN-200 | / | Unkown | |
| HY-181691 | JAK2-IN-20 | Inhibitor | / | Unkown |
| HY-181796 | TLR7 antagonist-1 | / | Unkown | |
| HY-181812 | JNK2/MKK7 PPI-IN-1 | Inhibitor | / | Unkown |
| HY-181818 | 4,5-Dehydro-6-oxoallosecurinine | / | Unkown | |
| HY-181826 | IL-17-IN-6 | Inhibitor | / | Unkown |
| HY-181827 | IL-17-IN-7 | Inhibitor | / | Unkown |
| HY-181872 | JAK1-IN-20 | Inhibitor | / | Unkown |
| HY-181926 | COX-2/HDAC6-IN-1 | / | Unkown | |
| HY-181937 | Multi-target kinase-IN-10 | Inhibitor | / | Unkown |
| HY-182006 | TNF-α-IN-28 | Inhibitor | / | Unkown |
| HY-182060 | PDE4B/D-IN-5 | / | Unkown | |
| HY-182241 | JR4-187 | / | Unkown | |
| HY-182267 | Antibiofilm agent-20 | Inhibitor | / | Unkown |
| HY-182268 | Antibiofilm agent-21 | / | Unkown | |
| HY-182282 | PI3K/AKT-IN-6 | Inhibitor | / | Unkown |
| HY-182283 | sEH-IN-23 | Inhibitor | / | Unkown |
| HY-182307 | OH14 | Inducer | / | Unkown |
| HY-182308 | LC-PDA-01 | Inhibitor | / | Unkown |
| HY-182369 | VA06 | Inhibitor | / | Unkown |
| HY-182377 | DT-5461 | Antagonist | / | Unkown |
| HY-182469 | FuBIG | / | Unkown | |
| HY-182503 | GP515 | Inhibitor | / | Unkown |
| HY-182579 | CBS-3408 | Inhibitor | / | Unkown |
| HY-182596 | INHIB1X | Inhibitor | / | Unkown |
| HY-182630 | CJ-14897 | Inhibitor | / | Unkown |
| HY-182707 | JWX-A0108 | / | Unkown | |
| HY-182777 | HDAC6-IN-80 | Inhibitor | / | Unkown |
| HY-182884 | TNF-α-IN-29 | Inhibitor | / | Unkown |
| HY-183042 | p38α-IN-12 | Inhibitor | / | Unkown |
| HY-183074 | RO8323 | / | Unkown | |
| HY-183098 | UNC8209 | / | Unkown | |
| HY-183252 | ICA-1S | / | Unkown | |
| HY-183288 | COX-2-IN-66 | Inhibitor | / | Unkown |
| HY-183325 | FTO-IN-17 | Inhibitor | / | Unkown |
| HY-183341 | sEH/AChE-IN-5 | / | Unkown | |
| HY-183357 | GABAAR/5-HT2AR modulator-1 | / | Unkown | |
| HY-183367 | Anti-inflammatory agent 115 | Inhibitor | / | Unkown |
| HY-183537 | KSI-028 | Inhibitor | / | Unkown |
| HY-183545 | sEH-IN-24 | Inhibitor | / | Unkown |
| HY-183564 | RIPK1/RIPK3-PPI-IN-1 | Inhibitor | / | Unkown |
| HY-183569 | CSF1R-IN-27 | Inhibitor | / | Unkown |
| HY-183599 | MK-1088 | Antagonist | / | Unkown |
| HY-183692 | FXR agonist 18 | / | Unkown | |
| HY-183764 | COX-2/5-LOX-IN-8 | Inhibitor | / | Unkown |
| HY-184324 | Anti-inflammatory agent 116 | Inhibitor | / | Unkown |
| HY-184341 | Anti-inflammatory agent 118 | Inhibitor | / | Unkown |
| HY-184354 | NO-Pravastatin | / | Unkown | |
| HY-184385 | PI3K/AKT/JAK2-IN-1 | Inhibitor | / | Unkown |
| HY-185709 | 2-ARA-LysoPtdEtn | / | Unkown | |
| HY-18754 | FR 167653 free base | Inhibitor | / | Unkown |
| HY-18759 | BMS-751324 | Inhibitor | / | Unkown |
| HY-18794 | R-03201195 | Inhibitor | / | Unkown |
| HY-19570A | NSC 15830 hydrochloride | Inhibitor | / | Unkown |
| HY-19717S | DCVC-13C3,15N | / | Unkown | |
| HY-201403 | LY2775240 | Inhibitor | / | Unkown |
| HY-B0742S1 | Hydroxyprogesterone caproate-d8 | Ligand | / | Unkown |
| HY-N0041R | Ginsenoside Rb3 (Standard) | Inhibitor | / | Unkown |
| HY-N0043R | Ginsenoside Rd (Standard) | Inhibitor | / | Unkown |
| HY-N0604R | Ginsenoside Rh1 (Standard) | Inhibitor | / | Unkown |
| HY-N0722A | (Z)-Neochlorogenic acid | / | Unkown | |
| HY-N0803S | Myrcene-d6 | Inhibitor | / | Unkown |
| HY-N10009 | Cudraflavone B | / | Unkown | |
| HY-N10047 | 7,8-Didehydrocimigenol | Inhibitor | / | Unkown |
| HY-N10423 | Cubebin | / | Unkown | |
| HY-N10448 | Sinulatumolin E | Inhibitor | / | Unkown |
| HY-N10453 | Sinulatumolin D | / | Unkown | |
| HY-N10454 | Sinulatumolin C | Inhibitor | / | Unkown |
| HY-N10835 | Gnetumontanin B | / | Unkown | |
| HY-N11892 | 7-O-Methylaloesinol | Inhibitor | / | Unkown |
| HY-N11996 | Aloenin aglycone | / | Unkown | |
| HY-N12042 | Taxamairin B | Inhibitor | / | Unkown |
| HY-N12104 | Trichodimerol | Inhibitor | / | Unkown |
| HY-N12186 | Sibiricine | / | Unkown | |
| HY-N12653 | Exserohilone | Inhibitor | / | Unkown |
| HY-N12743 | Farobin A | Inhibitor | / | Unkown |
| HY-N13114 | 8-Gingerdione | / | Unkown | |
| HY-N1326 | Santamarine | 98.85% | Unkown | |
| HY-N13817 | (8R,12R,13R)-8,12-Epoxylabd-14-en-13-ol | Inhibitor | / | Unkown |
| HY-N13828 | 1-Prenyl-2-methoxy-6-formyl-8-hydroxy-9H-carbazole | Inhibitor | / | Unkown |
| HY-N15305 | Ferolin | Agonist | / | Unkown |
| HY-N15519 | Crocatin B | Inhibitor | / | Unkown |
| HY-N15570 | 2-O-Methylatromentin | Inhibitor | / | Unkown |
| HY-N15589 | 8-(6,7-Dihydroxy-3,7-dimethyl-2E-octenyloxy)psoralen | Inhibitor | / | Unkown |
| HY-N15653 | Heveadride | Inhibitor | / | Unkown |
| HY-N15708 | Dichotomine C | Inhibitor | / | Unkown |
| HY-N16066 | Candidusin A | / | Unkown | |
| HY-N16527 | 7-O-Galloyl-D-sedoheptulose | Inhibitor | / | Unkown |
| HY-N16620 | Gnetucleistol F | Inhibitor | / | Unkown |
| HY-N16637 | (3R,5R)-3,5-Dihydroxy-1,7-bis(3,4-dihydroxyphenyl)heptane 3-O-β-D-glucopyranoside | Inhibitor | / | Unkown |
| HY-N16732 | Isoconiferinoside | Control | / | Unkown |
| HY-N17239 | Oleracone | Inhibitor | / | Unkown |
| HY-N17317 | Isostrictiniin | / | Unkown | |
| HY-N17326 | Ilekudinol B | Inhibitor | / | Unkown |
| HY-N17353 | Vitedoamine A | Inhibitor | / | Unkown |
| HY-N17395 | (6R,7R)-Epoxy-1-oleanen-3-ol | Inhibitor | / | Unkown |
| HY-N17562 | Acutissimalignan B | Inhibitor | / | Unkown |
| HY-N17685 | Pseudoginsenoside RT4 | / | Unkown | |
| HY-N17727 | Divaricatol | / | Unkown | |
| HY-N17736 | Chikusetsusaponin IVa methyl ester | / | Unkown | |
| HY-N17773 | Hydrangeic acid | Inhibitor | / | Unkown |
| HY-N17779 | 3-O-Caffeoyl-5-O-feruloylquinic acid | Inhibitor | / | Unkown |
| HY-N17783A | Sanleng acid | / | Unkown | |
| HY-N17821 | Butrin | / | Unkown | |
| HY-N17853 | Siaresinolic acid | / | Unkown | |
| HY-N17855 | Guavinoside B | Inhibitor | / | Unkown |
| HY-N18025 | Kaempferol 3-O-(2G-glucosylrutinoside)-7-O-glucoside | Inhibitor | / | Unkown |
| HY-N18197 | Norkurarinol | / | Unkown | |
| HY-N1928 | Dauricinoline | Inhibitor | / | Unkown |
| HY-N19615 | Isoeucommin A | / | Unkown | |
| HY-N19640 | (20S)-18,20-Epoxydigitoxigenin α-L-thvetoside | / | Unkown | |
| HY-N19727 | Chamissonolide | Inhibitor | / | Unkown |
| HY-N19801 | N-Palmitoyl-D-glucosamine | / | Unkown | |
| HY-N19816 | 7-O-Methyl glabranin | Inhibitor | / | Unkown |
| HY-N3364 | Lucidone | Inhibitor | / | Unkown |
| HY-N3380 | Linderaspirone A | Inhibitor | / | Unkown |
| HY-N3421 | Koaburaside | Inhibitor | / | Unkown |
| HY-N3552 | Catalposide | Inhibitor | 98.0% | Unkown |
| HY-N3602A | rel-Cleroindicin F | Inhibitor | / | Unkown |
| HY-N3625 | Coronalolic acid | Inhibitor | / | Unkown |
| HY-N3807S | Enniatin B1-13C34 | / | Unkown | |
| HY-N4061 | Hedycoronen A | Inhibitor | / | Unkown |
| HY-N4275 | Oleaside A | / | Unkown | |
| HY-N6969A | Dicentrine hydrochloride | Antagonist | / | Unkown |
| HY-N7699A | D-Trimannuronic acid | Activator | / | Unkown |
| HY-N8529 | Eupalestin | Inhibitor | / | Unkown |
| HY-N8593S | Undecane-d24 | / | Unkown | |
| HY-N8712 | Umckalin | / | Unkown | |
| HY-N8816 | Stipuleanoside R2 | / | Unkown | |
| HY-N8936 | Narchinol B | / | Unkown | |
| HY-N9000 | Loganic acid 6′-O-β-D-glucoside | / | Unkown | |
| HY-N9558 | 12-Hydroxydehydroabietic acid | / | Unkown | |
| HY-N9566 | Isopongaflavone | Inhibitor | / | Unkown |
| HY-N9587 | Tricin 7-O-β-D-glucopyranoside | Inducer | 99.23% | Unkown |
| HY-N9699 | 8α-Hydroxyhirsutinolide | Inhibitor | / | Unkown |
| HY-N9731 | 6-O-p-Hydroxybenzoylglutinoside | Inhibitor | / | Unkown |
| HY-P0071 | F 991 | Inhibitor | / | Unkown |
| HY-P10241 | Ac-LEHD-CHO | Inhibitor | / | Unkown |
| HY-P10350 | PapRIV | Agonist | / | Unkown |
| HY-P10693 | CZEN-002 | Inhibitor | / | Unkown |
| HY-P10770 | P-ESBP-DOX | Inhibitor | / | Unkown |
| HY-P10796 | YARA peptide | Inhibitor | / | Unkown |
| HY-P10850 | PIYLGGVFQ | / | Unkown | |
| HY-P10994 | Eps8 peptide 327 | / | Unkown | |
| HY-P10995 | TAT-327 | / | Unkown | |
| HY-P11093 | Papiliocin | / | Unkown | |
| HY-P11098 | Peptide HV2 | Inhibitor | / | Unkown |
| HY-P11161 | Fowlicidin-2 | Inhibitor | / | Unkown |
| HY-P11214 | Hydrostatin-TL1 | / | Unkown | |
| HY-P11250 | HVF18-a3-d | Inhibitor | / | Unkown |
| HY-P11296 | LLVK | Inhibitor | / | Unkown |
| HY-P11614 | LCA-H10 | / | Unkown | |
| HY-P11616 | WK2 | Inhibitor | / | Unkown |
| HY-P11617 | CLP-d2 | Inhibitor | / | Unkown |
| HY-P11736 | mcIRBP-9 | Inhibitor | / | Unkown |
| HY-P11772 | LBP-14 | / | Unkown | |
| HY-P11833 | TNFR1-IN-1 | Inhibitor | / | Unkown |
| HY-P11834 | TNFR1-IN-2 | Inhibitor | / | Unkown |
| HY-P1832 | PTD-p65-P1 Peptide | / | Unkown | |
| HY-P1847 | IKKγ NBD Inhibitory Peptide | / | Unkown | |
| HY-P1924A | IRBP(651-670) human, mouse TFA | Activator | / | Unkown |
| HY-P3149 | LEESGGGLVQPGGSMK | / | Unkown | |
| HY-P3149A | LEESGGGLVQPGGSMK TFA | / | Unkown | |
| HY-P3168 | Martentoxin | Inhibitor | / | Unkown |
| HY-P3203 | DSTYSLSSTLTLSK | / | Unkown | |
| HY-P3483 | Maxadilan | / | Unkown | |
| HY-P5838 | Citrullinated LL-37 5cit | Inhibitor | / | Unkown |
| HY-RS14786 | TNF Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008829 | N,N-Diethylacetamide | 99.68% | Unkown | |
| HY-W010201S1 | Citronellol-d3 | / | Unkown | |
| HY-W010270A | Aurothiomalate disodium | Inhibitor | / | Unkown |
| HY-W014049 | N'-Nitro-D-arginine | Inhibitor | / | Unkown |
| HY-W040045R | Callistephin chloride (Standard) | Inhibitor | / | Unkown |
| HY-W104821 | Rosolic acid | Activator | / | Unkown |
| HY-W338346 | Salicylate choline | Inhibitor | / | Unkown |
| HY-W424851 | DPQ hydrochloride | Inhibitor | / | Unkown |
| HY-W665882 | Norketotifen | Inhibitor | / | Unkown |
| HY-W709413 | Panaxytriol | / | Unkown | |
| HY-W744192 | 2-Hydroxy Imiquimod | Inducer | / | Unkown |
| HY-W750980 | β-Bisabolol | Inhibitor | / | Unkown |
| HY-W753956 | Iminostilbene-d10 | / | Unkown | |
| HY-W761985 | Furathiocarb | / | Unkown | |
| HY-W777458 | Fluorene-13C6 | / | Unkown | |
| HY-W852084 | S-27609 | / | Unkown | |
| HY-W971442 | Moniliphenone | Inhibitor | / | Unkown |
| HY-W995241 | BPD | Inhibitor | / | Unkown |
| HY-101546A | Cavidine | Inhibitor | / | Unkown |
| HY-107091R | Aspartyl-alanyl-diketopiperazine (Standard) | Inhibitor | / | Unkown |
| HY-108162 | Ataquimast free base | Inhibitor | / | Unkown |
| HY-110133A | JTE-607 free base | Inhibitor | / | Unkown |
| HY-110343 | DBM 1285 dihydrochloride | Inhibitor | / | Unkown |
| HY-113440R | 5-Methoxytryptophol (Standard) | / | Unkown | |
| HY-116426 | IDT | Modulator | / | Unkown |
| HY-117622 | ND-2110 | Inhibitor | / | Unkown |
| HY-118984 | CRX-526 | Antagonist | / | Unkown |
| HY-119420 | Acetoxycycloheximide | / | Unkown | |
| HY-119799 | UK-500001 | Inhibitor | / | Unkown |
| HY-12085S1 | Apremilast-d8 | / | Unkown | |
| HY-12348 | LEO 29102 | Inhibitor | / | Unkown |
| HY-126031 | (R)-KT109 | Inhibitor | / | Unkown |
| HY-126211 | KBH-A42 | Inhibitor | / | Unkown |
| HY-128776 | Antitumor agent-19 | Activator | / | Unkown |
| HY-130073 | Amorfrutin A | / | Unkown | |
| HY-134070 | 2-O-Methyl PAF C-16 | Activator | / | Unkown |
| HY-138056 | 7-Acetyl paclitaxel | 98.35% | Unkown | |
| HY-138063 | Siegeskaurolic acid | Inhibitor | / | Unkown |
| HY-14909R | Bardoxolone (Standard) | / | Unkown | |
| HY-15495B | (3S)-Tanzisertib hydrochloride | Inhibitor | / | Unkown |
| HY-156297 | β5i-IN-1 | Inhibitor | / | Unkown |
| HY-156431 | Anti-inflammatory agent 61 | Inhibitor | / | Unkown |
| HY-160121 | Patrinoside aglucone | Inhibitor | / | Unkown |
| HY-160713 | Betamethasone succinate | Inhibitor | / | Unkown |
| HY-162579 | TLR7 agonist 22 | Agonist | / | Unkown |
| HY-163712 | 17-Epiestriol | Agonist | / | Unkown |
| HY-165553 | ASB16165 | Inhibitor | / | Unkown |
| HY-16658C | Z-VA-DL-D-FMK | Inhibitor | / | Unkown |
| HY-167632 | meso-Zeaxanthin | 93.09% | Unkown | |
| HY-167754 | Resolvin D5 n-3 DPA | Agonist | / | Unkown |
| HY-168384 | M04 | / | Unkown | |
| HY-168770 | Cl-Necrostatin-1 | Inhibitor | / | Unkown |
| HY-168782 | Resolvin D2 n-3 DPA | Inhibitor | / | Unkown |
| HY-171254 | p38-α MAPK-IN-9 | Inhibitor | / | Unkown |
| HY-171295 | p38 Kinase inhibitor 7 | Inhibitor | / | Unkown |
| HY-171906 | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA | Inhibitor | / | Unkown |
| HY-172195 | FS-694 | Inhibitor | / | Unkown |
| HY-173388 | TLR4-IN-2 | Inhibitor | / | Unkown |
| HY-173485 | SARS-CoV-2 Mpro-IN-41 | Inhibitor | / | Unkown |
| HY-173595 | ODE-(S)-HPMPA formate | / | Unkown | |
| HY-174512 | Human TNFSF8 mRNA | / | Unkown | |
| HY-174513 | Human TNFRSF8 mRNA | / | Unkown | |
| HY-174514 | Human TNFRSF4 mRNA | / | Unkown | |
| HY-174515 | Human TNFRSF1B mRNA | / | Unkown | |
| HY-174516 | Human TNFRSF1A mRNA | / | Unkown | |
| HY-174517 | Human TNFRSF14 mRNA | / | Unkown | |
| HY-174518 | Human TNF mRNA | / | Unkown | |
| HY-174587 | Human LTB mRNA | / | Unkown | |
| HY-174714 | Human FAS mRNA | / | Unkown | |
| HY-174738 | Human CD40 mRNA | / | Unkown | |
| HY-174842 | HTS05585 | Inhibitor | / | Unkown |
| HY-176466 | ST-899 | / | Unkown | |
| HY-177406 | VR11 aptamer | Inhibitor | / | Unkown |
| HY-180271 | Xanthine oxidase-IN-21 | Inhibitor | / | Unkown |
| HY-181507 | CD28-IN-3 | Inhibitor | / | Unkown |
| HY-183008 | BSF2 | Inhibitor | / | Unkown |
| HY-183448 | ETMTC | / | Unkown | |
| HY-183533 | Cytokine-IN-1 | Inhibitor | / | Unkown |
| HY-B0679S | Lubiprostone-d7 | / | Unkown | |
| HY-B0898S | Ceftiofur-d3 sodium | Inhibitor | / | Unkown |
| HY-B1451S | Imidapril-d3 hydrochloride | Inhibitor | / | Unkown |
| HY-B1670 | (-)-Isoproterenol | Inhibitor | / | Unkown |
| HY-N0346 | 4-Methoxycinnamic acid ethyl ester | 98.72% | Unkown | |
| HY-N0631R | Cornuside (Standard) | Inhibitor | / | Unkown |
| HY-N0803S1 | Myrcene-13C3 | Inhibitor | / | Unkown |
| HY-N0852R | Benzoylpaeoniflorin (Standard) | / | Unkown | |
| HY-N0976 | 1,11b-Dihydro-11b-hydroxymedicarpin | Activator | / | Unkown |
| HY-N10175 | Berkeleyacetal C | / | Unkown | |
| HY-N11072 | Tremulacin | Inhibitor | 96.41% | Unkown |
| HY-N1125 | Triptobenzene H | Inhibitor | / | Unkown |
| HY-N11262 | Sudachitin | / | Unkown | |
| HY-N1151 | Thunberginol C | Inhibitor | / | Unkown |
| HY-N1159 | Teuclatriol | Inhibitor | / | Unkown |
| HY-N11994 | Aloeresin G | Inhibitor | / | Unkown |
| HY-N12116 | Maceneolignan A | Inhibitor | / | Unkown |
| HY-N12905 | Celastramycin A (isomer) | Inhibitor | / | Unkown |
| HY-N14533 | Quinolactacin A2 | Inhibitor | / | Unkown |
| HY-N14780 | Pochonin D | / | Unkown | |
| HY-N15307 | Trigraecum | Inhibitor | / | Unkown |
| HY-N15347 | Talaromyketide B | Inhibitor | / | Unkown |
| HY-N15378 | β-Carotene-15,15'-epoxide | / | Unkown | |
| HY-N15415 | Zaluzanin C | / | Unkown | |
| HY-N15564 | Theleganbanin B | / | Unkown | |
| HY-N15566 | Theleganbanin D | / | Unkown | |
| HY-N17277 | Indigoticoside A | Inhibitor | / | Unkown |
| HY-N3700 | Decarine | / | Unkown | |
| HY-N7056R | 4'-Hydroxychalcone (Standard) | Inhibitor | / | Unkown |
| HY-N7697C | Chitohexaose hexahydrochloride | 95.0% | Unkown | |
| HY-N7773 | Hibiscetin | / | Unkown | |
| HY-N8712R | Umckalin (Standard) | / | Unkown | |
| HY-N9086A | (rac)-Poriol | Ligand | / | Unkown |
| HY-N9164 | Hecubine | / | Unkown | |
| HY-N9541 | Chaetoglobosin Vb | / | Unkown | |
| HY-W010201S | Citronellol-d6 | Activator | / | Unkown |
| HY-W071581 | Glucocorticoid receptor activator 1 | Activator | / | Unkown |
| HY-W273493 | 4-Nitrochalcone | / | Unkown | |
| HY-W505984 | TPNA10168 | Activator | / | Unkown |
| HY-W745349 | rel-(1S,2R)-Dihydro bupropion-d9 hydrochloride | Inhibitor | / | Unkown |
| HY-W777138 | rel-(1S,2R)-Dihydro bupropion-d9 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(23)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9970A | Infliximab (Anti-TNF-α) | Inhibitor | 99.00% | Unkown |
| HY-P990008 | Atrosab | 99.94% | Unkown | |
| HY-P99148 | Anti-Mouse/Rat/Rabbit TNF alpha Antibody (TN3-19.12) | Inhibitor | 99.24% | Unkown |
| HY-P990794 | Anti-Mouse TNF-alpha/TNFSF2 Antibody (XT3.11) | Inhibitor | 98.19% | Unkown |
| HY-P990907 | Brivekimig | Inhibitor | 98% | Unkown |
| HY-P990242 | Anti-Mouse Galectin-9 Antibody (RG9-1) | Inhibitor | 95.64% | Unkown |
| HY-P991440 | AMG-966 | Inhibitor | 96.19% | Unkown |
| HY-P991400 | GSK1995057 | 99.09% | Unkown | |
| HY-P99782 | Opinercept | Inhibitor | / | Unkown |
| HY-P991682 | Emzotamig | Inhibitor | / | Unkown |
| HY-P992132 | Solaprubart | Inhibitor | 99.59% | Unkown |
| HY-P992201 | Anti-CD160 Antibody (MAT 302) | / | Unkown | |
| HY-P991274 | BMS-986010 | Inhibitor | / | Unkown |
| HY-P991426 | MB-314 | / | Unkown | |
| HY-P991432 | VTX-0811 | / | Unkown | |
| HY-P991789 | Anti-Mouse NKp46 Antibody (29A1.4) | Inhibitor | / | Unkown |
| HY-P991821 | Anti-Mouse CD120a Antibody (55R-170) | Inhibitor | / | Unkown |
| HY-P992021 | WM-A1-3389 | Inhibitor | / | Unkown |
| HY-P992153 | Serrumab | Inhibitor | / | Unkown |
| HY-P992399 | LBL-019 | / | Unkown | |
| HY-P992401 | M802 | / | Unkown | |
| HY-P992487 | ZL-1211 | / | Unkown | |
| HY-P99753 | Nerelimomab | Inhibitor | / | Unkown |